Removing osteopontin from mice with muscular dystrophy reduces inflammation and fibrosis, boosting muscle repair and regeneration. Osteopontin inhibitors may be used to slow disease progression and improve muscle function in DMD patients.
Researchers found that SLE neutrophils release oxidized mitochondrial DNA, stimulating type I interferon production and contributing to disease pathogenesis. Targeting pathways for oxidized DNA degradation may offer new treatment options for chronic autoimmune disease.
A new study reveals that muscles controlling the eyes and eyelids are selectively spared in Duchenne muscular dystrophy due to higher utrophin levels. Researchers also found ECC machinery and calcium regulation similar to those of quadriceps muscles, challenging current understanding of muscle function.
A metabolic pathway up-regulated in certain breast cancers promotes disease progression by activating the cell signaling protein Arf6, according to a recent study. Statin-like drugs may be effective treatments for patients whose tumors express high levels of Arf6 signaling proteins.
Researchers have found that transient bladder contractions play a crucial role in sensing pressure and conveying information to sensory nerves. The frequency and rate of rise of these contractions may be fine-tuned by other cell types, offering potential targets for therapeutic intervention in urinary bladder dysfunction.
The ROBO1 signaling pathway enhances cellular contractility and adhesion in response to stiff environments, allowing cells to retain shape and position. This upregulation of ROBO1 may prevent cell invasion and delay tumor progression.
A peptide derived from collagen protein promotes the formation of neuronal synapses in the brain, potentially helping to treat schizophrenia. Collagen XIX-deficient mice display symptoms similar to those seen in humans with the disorder.
Researchers found that Retigabine enhances the resting potential open state stability of K7.2/K7.3 channels, increasing potassium ion flow and decreasing electrical signals. This may help refine pharmacotherapy for epilepsy and related disorders.
Researchers developed a muscle-on-a-chip model that demonstrates how cardiac stem cell therapies can fail due to inefficient force transmission between new and old heart cells. The study suggests that mechanical forces are not transmitted properly, leading to the formation of cellular adhesions that dissipate force to surrounding tissues.
A new study found that IL-33 amplifies an innate immune response in the degenerating retina, leading to retinal cell death. Inhibiting IL-33 may help treat AMD and other retinal degenerative diseases.
Researchers identified a nuclear receptor protein called RXRgamma, which promotes OPC differentiation and remyelination. A vitamin D-activating drug may enhance remyelination in MS patients by controlling myelin sheath regeneration.
Cancer cells can be made vulnerable to autophagy shutdown by combining an FLT3 inhibitor with an autophagy blocker. This combination prevents cancer cells from metabolizing glucose and mobilizing stored nutrients, leading to cell death. The study provides evidence that this approach could be a new way to treat various types of cancer.
Researchers found that miR-7 directly targets and suppresses the activity of growth factor receptor IGF1R, as well as the pro-oncogenic NF-κB pathway. Increasing miR-7 levels reduced tumor growth in mice and correlated with improved patient survival.
Scientists have uncovered a port of entry for malaria parasites in the liver, highlighting a potential new drug target. The discovery could help prevent the spread of disease and reduce malaria-related deaths worldwide.
Researchers discovered that memory CD4+ T cells linger in the skin for up to a year after resolving Leishmania infection. These skin-resident memory cells help reduce parasite numbers during secondary infections by recruiting blood-borne memory cells, suggesting a new approach to developing anti-Leishmania vaccines.
A new anti-basigin drug has cured mice of established malaria infection with minimal side effects, offering hope for treating the deadly disease. The drug's development path may be less complex than traditional clinical trials, as it builds on existing knowledge of the protein's role in cancer and graft-versus-host disease.
Researchers identified neutrophils as the bloody culprit behind immune cell-induced bleeding. Blocking neutrophil passage could prevent complications in transplant and chemotherapy patients.
Researchers discovered that Schwann cells digest damaged myelin internally through autophagy, clearing 40-50% of the myelin within 5-7 days. This mechanism enables significant nerve repair in the peripheral nervous system, contrasting with the CNS where oligodendrocytes fail to clear myelin.
Scientists found a thick band of microtubules in retina neurons that serve as a 'transport road' for mitochondria, crucial for sustained visual processing. This discovery sheds light on how bipolar cells meet their high energy demands.
Researchers have identified a way for malaria parasites to dodge anti-malarial drugs, surviving inside immature red blood cells and remaining sensitive to certain treatments. This finding may help guide future research and lead to the development of new anti-malarial drugs for refractory patients.
Researchers found that a Rab protein boosts PIP2 production, enabling HIV-1 assembly. Immune cells lacking this protein show impaired viral replication.
A study found that FOXO1, a protein promoting tissue repair, acts as an inhibitor of wound healing in diabetes patients. High glucose levels slow keratinocyte migration, while insulin speeds up the process. The research suggests inhibiting FOXO1 could speed healing in diabetic patients.
A study published in The Journal of General Physiology reveals the distinct roles of calcium channels in controlling arterial tone and blood flow to the brain. Researchers found that blocking L-type and T-type channels has opposite effects on blood flow, with one promoting vasodilation and the other constricting arteries.
Researchers discovered that a protein called Tmem231 plays a crucial role in regulating ciliary membrane composition and function. This study sheds light on the mechanisms underlying Meckel syndrome and other human diseases characterized by defects in cilia.
Researchers discovered an unconventional way serotonin is released from neurons, which could play a key role in antidepressant drug mechanism. The study suggests that the firing of serotonergic neurons is initially suppressed by extracellular serotonin.
A study published in The Journal of Cell Biology provides new insights into the relationship between two proteins associated with cerebral cavernous malformations. Researchers found that CCM3 has an independent role in cell proliferation or survival pathways, contributing to the severity of symptoms.
Cancer cells with high stress granule levels are more likely to metastasize. Removing YB-1 reduces stress granule formation and decreases metastatic spread in animal models.
Researchers discovered how NORE1A prevents excessive cell proliferation associated with cancer. Overexpressing NORE1A induced cell senescence, whereas removing the protein enhanced cancer-promoting Ras mutations. This study highlights the critical role of NORE1A in regulating tumor growth.
A study found Sall4 protein promotes DNA repair in embryonic stem cells, potentially aiding cancer cell survival. This discovery raises the possibility of targeting Sall4 for cancer treatment.
Researchers found that a secreted immune protein called interleukin(IL)-17B promotes pancreatic cancer growth and metastasis. Treating tumor-bearing mice with an IL-17B inhibitor halted tumor growth and spread, resulting in increased survival.
Phosphorylation and methylation of desmoplakin regulate its interaction with the cytoskeleton, affecting cell-to-cell connections. The study reveals a regulatory mechanism that contributes to skin and heart diseases.
Researchers found that deleting TREM2 receptor in mice with AD-like disease reduced plaque formation, brain inflammation, and improved neuron survival. Macrophages lacking TREM2 were more effective at clearing beta-amyloid aggregates, suggesting a potential role for the receptor in neurodegeneration.
Researchers found impaired energy metabolism in Mfn2-deficient cells due to reduced coenzyme Q levels. Supplementing with coenzyme Q partially restored respiratory chain function, suggesting a potential treatment for patients with Mitofusin 2 deficiency diseases.
Researchers have identified a specific population of stem cells in the skin that exclusively generate and maintain Merkel cells, crucial for touch sensation. Removing these cells led to a permanent reduction in Merkel cells, highlighting their unique role.
A study isolated the domain IV paddle of scorpion venom and found it remained sensitive to scorpion venom even when bound to a chip. This breakthrough could lead to faster identification of drugs that target this region, modifying sodium channel activity in beneficial ways.
Researchers found that mutant sodium channels with opposite effects on channel function can lead to disruptions in normal cardiac function due to ion leaks. This overload of positively charged ions within the cell may be a key mechanism linking these mutations to atypical arrhythmias and dilated cardiomyopathy.
Listeria uses distinct tactics to breach the intestine and placenta, utilizing protein phosphoinositide-3 kinase (PI3-K) for invasion. The study uncovers key differences in Listeria's internalin proteins and their role in PI3-K activation.
Researchers found that B cells from mutant mice with M6P deficiency and patients with mucolipidosis II present similar defects in antibody synthesis, indicating a critical role of M6P in B cell function. Other immune cells, such as dendritic cells and T cells, were less severely affected.
A new study reveals that macrophages induce neutrophil reverse migration to resolve inflammation in wounds. Without macrophages, neutrophils remain in wounds longer, leading to recurring infections and exaggerated inflammation.
B cells use a unique migration strategy in the bone marrow that allows them to exit slowly and be passively swept out by blood flow. The researchers found that the absence of CXCR4 significantly slows down B cell movement, highlighting the importance of this protein in regulating immune cell egress.
A study published in The Journal of General Physiology has found that commonly used anesthetics affect ion channel proteins, impairing cell-to-cell communication. This discovery could lead to the development of improved anesthetics with fewer side effects.
A newly discovered signaling pathway in brown fat cells stimulates glucose uptake, potentially treating type 2 diabetes. The mTORC2 pathway, involving protein kinase mTOR, enhances GLUT1 transport to the surface of brown fat cells.
Researchers discovered flu infection prompts immune cells to migrate to gut, altering bacterial composition and causing inflammation that promotes tissue injury. Blocking inflammatory molecules or antibiotics attenuates intestinal injury, suggesting relief options for flu-induced gastrointestinal symptoms.
A recent study published in The Journal of Experimental Medicine found that obesity can lead to lethal inflammation in response to certain anti-cancer therapies. This suggests that preclinical studies on young mice may not accurately predict outcomes in older patients, who are more likely to be overweight and develop cancer.
A study found that Staphylococcus aureus uses protein A as a superantigen to activate many B cells, leading to immune tunnel vision and reduced protection against infection. This knowledge can inform future vaccine approaches to combat MRSA.
A study found that excessive myofibroblast activity during wound healing leads to increased ECM organization, promoting the release of active TGF-β1. This activation then induces further myofibroblast activity and fibrosis.
Researchers found that asynchronous cell repair causes muscle fibrosis in Duchenne muscular dystrophy patients, leading to progressive weakness and tissue replacement. This study suggests that resynchronizing regenerative processes could be a potential treatment for fibrosis.
Researchers successfully induced a rare type of blood cancer in mice using a single stem cell with the mutated JAK2 protein. The resulting cancer cells also retained the JAK2 mutation, offering new insights into the disease's progression.
Researchers have identified a better measure of predicting cancer neoepitopes, which are specific protein sequences recognized by immune cells. This new approach has the potential to improve current methods for generating anticancer vaccines, increasing their effectiveness in combating cancer.
Patients with common variable immunodeficiency (CVID) experience recurrent bacterial infections due to exhausted T cells expressing inhibitory protein PD-1. Rejuvenating these cells through blocking PD-1 may offer protection against bacterial infections, suggesting a potential therapeutic strategy.